Analysis

The consumer goods titan Procter & Gamble has laid out an ambitious capital return program for its 2026 fiscal year,...

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...

While its share price remains significantly depressed from its July 2025 peak, Strategy is adopting a notably aggressive posture. The...

In an unusually broad product launch outside its traditional September cycle, Apple has initiated its most extensive hardware offensive of...

The investment community is closely monitoring Outlook Therapeutics as it navigates a decisive period for its flagship ophthalmic drug. While...

Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...

A new and alarming risk has emerged for cloud computing giant Amazon. For the first time in the sector's history,...

Investor relief has propelled the stock of the streaming market leader to significant gains. The company's decision to formally withdraw...

The industrial software company PTC is intensifying its pivot toward cloud-native solutions, aiming to enhance efficiency within manufacturing sectors. This...

Axsome Therapeutics is embarking on a significant commercial and regulatory push. The biopharmaceutical company aims to solidify its position in...